Ledger.Open graph →
SEC Form D · filed July 1, 2025

Quince Therapeutics, Inc

Offering
$21.9M
Sold
$11.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Una Ryan · Marlborough, MADirectorDavid Lamond · San Francisco, CADirectorChristopher Senner · South San Francisco, CADirectorCharles Ryan · Stony Brook, NYExecMargi Mcloughlin · South San Francisco, CADirectorJune Bray · South San Francisco, CADirectorLuca Benatti · South San Francisco, CADirectorBrendan Hannah · South San Francisco, CAExecDirk Thye · San Diego, CAExec · DirectorRajiv Patni · South San Francisco, CADirectorUna Ryan · New Haven, CTDirectorDavid Lamond · San Francisco, CADirectorChristopher Senner · South San Francisco, CADirectorCharles Ryan · Boston, MAExecMargi Mcloughlin · South San Francisco, CADirectorJune Bray · South San Francisco, CADirectorLuca Benatti · South San Francisco, CADirectorBrendan Hannah · South San Francisco, CAExecDirk Thye · San Diego, CAExec · DirectorRajiv Patni · South San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗